- Home
- SYPR vs IGC Comparison
SYPR vs IGC Comparison
Compare SYPR & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYPR
- IGC
- Stock Information
- Founded
- SYPR 1997
- IGC 2005
- Country
- SYPR United States
- IGC United States
- Employees
- SYPR N/A
- IGC N/A
- Industry
- SYPR Industrial Machinery/Components
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- SYPR Industrials
- IGC Health Care
- Exchange
- SYPR Nasdaq
- IGC Nasdaq
- Market Cap
- SYPR 47.9M
- IGC 39.8M
- IPO Year
- SYPR 1994
- IGC N/A
- Fundamental
- Price
- SYPR $2.32
- IGC $0.41
- Analyst Decision
- SYPR
- IGC Strong Buy
- Analyst Count
- SYPR 0
- IGC 2
- Target Price
- SYPR N/A
- IGC $4.00
- AVG Volume (30 Days)
- SYPR 60.4K
- IGC 667.7K
- Earning Date
- SYPR 11-11-2025
- IGC 11-11-2025
- Dividend Yield
- SYPR N/A
- IGC N/A
- EPS Growth
- SYPR N/A
- IGC N/A
- EPS
- SYPR N/A
- IGC N/A
- Revenue
- SYPR $130,040,000.00
- IGC $1,327,000.00
- Revenue This Year
- SYPR N/A
- IGC $15.26
- Revenue Next Year
- SYPR N/A
- IGC $3.41
- P/E Ratio
- SYPR N/A
- IGC N/A
- Revenue Growth
- SYPR N/A
- IGC 24.95
- 52 Week Low
- SYPR $1.30
- IGC $0.25
- 52 Week High
- SYPR $3.72
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- SYPR 58.65
- IGC 50.95
- Support Level
- SYPR $2.00
- IGC $0.39
- Resistance Level
- SYPR $2.45
- IGC $0.43
- Average True Range (ATR)
- SYPR 0.14
- IGC 0.02
- MACD
- SYPR 0.01
- IGC -0.00
- Stochastic Oscillator
- SYPR 71.11
- IGC 37.17
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.